External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology Retina Society 2020
Roche and Genentech at

Retina Society 2020

September 21 - September 22
New York, USA
retinasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:00 AM
Duration 6mins Virtual
Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure Optimization and Use of Virtual Reality (VR) Simulators in PDS Trials
Miller, D, Gune S, Barteselli G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Virtual
What Happens to Diabetic Retinopathy Severity With Less Frequent Ranibizumab Treatment? A Post Hoc Analysis of the RISE/RIDE Open-Label Extension Study
Goldberg R, Hill L, Abolian A, Stoilov I
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 6mins Virtual
Key Learnings from the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab (PDS) in Patients with Neovascular AMD
Eichenbaum D, Blotner S, Barteselli G, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 6mins Virtual
Effect of Dual Angiopoietin-2/VEGF-A Inhibition with Faricimab on Macular Anatomy in the STAIRWAY Phase 2 Study of Neovascular Age-Related Macular Degeneration
Lad E, Lin H, Silverman D, Basu, K, Quezada C, Haskova Z
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Virtual
Macular Atrophy (MA) in the Phase 2 Ladder Trial
Jaffe G, Barteselli G, Lin C-Y, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Virtual
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial
Pieramici D, Gune S, Maass K, Maia M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 6mins Virtual
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD (nAMD)
Awh C, Singh N, Kaufman D, Kardatzke D, Patel S, Gune S, Barteselli G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.